🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on the fourteenth of October at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our family has dimmed his light for us in the present world,” his family confirmed. “After a lengthy and brave battle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his innovative modern soul style and collaborations with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his artistic journey into the limelight. The album debuted at the top spot on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal featured the singer, famously stripped down to his waist, singing straight into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a severe car crash that left him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further top chart entry on the R&B chart and a award for Top R&B Record.

Again, in his own enigmatic way, D’Angelo made only a few public appearances in the following years.

The singer was announced as a top act for the 2025 music event, but his performance was canceled, due to an “unforeseen medical delay.”

Although information is limited about D’Angelo’s health in the weeks leading up to his passing, he had apparently been hospitalized for months and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose existence was cut short.

“We are grieved that he can only provide cherished moments with his loved ones, but we are forever thankful for the heritage of extraordinarily moving songs he has left us,” his family said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy affects the digestive organ, a tiny gland that generates the hormone insulin and is vital in digestion, among other functions. The position and dimensions of the organ in the body make it more challenging to detect malignancy.

Although pancreatic cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for 7% of malignancy fatalities.

Nearly seventy thousand individuals will be diagnosed with this condition and roughly 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have limited and ineffective treatment options, and a narrow opportunity to make a meaningful impact on the lives of patients,” said a cancer specialist.

Since this disease seldom produces early symptoms, it’s frequently diagnosed only once the condition is advanced. Even when a individual has indicators they are usually vague and may be confused with a several everyday ailments.

“As of yet, there is no effective method to identify this malignancy in the initial phases, apart from listening to your body and consulting your physician if there are unfamiliar symptoms,” said a medical director.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• weight loss
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as this malignancy is most common in individuals in the 65 to 75 age bracket. However, many cancers, such as this type, have become more common in younger people.

“Pancreatic cancer diagnosed prior to fifty is considered rare, yet alarmingly, doctors are beginning to see a rising count of younger patients affected by this disease,” commented a specialist.

Family History Impacts Cancer Risk

In the absence of effective screening tools for this malignancy, professionals stressed the importance of knowing your family’s cancer history. Some contributing elements, such as tobacco use and obesity also play a role in the onset of this disease.

African Americans have the highest incidence of pancreatic cancer in the United States and are most likely to be diagnosed with untreatable disease.

“The initial action toward lowering one’s risk of this condition is assessing personal risk factors. People should review their family history, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may increase their susceptibility,” said a medical professional.

Hereditary elements are associated with as much as ten percent of all this malignancy cases. If a relative in your household has had pancreatic cancer, you may want to think about genetic testing.

“For people with a family history of this condition or those having high risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find initial alterations in the pancreas,” he clarified.

For those looking to lower their chance, lifestyle changes may have an effect. The best action you can take to reduce your susceptibility of this disease is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreas inflammation, a contributing element for pancreatic cancer, so limiting or abstaining from drinks may help lower your chance.

Managing your body mass or losing weight may also aid reduce your risk. People with obesity are 20% more likely to develop this disease. This malignancy also occurs more often in those with diabetes, and weight loss can also reduce the chance of type 2 diabetes.

Despite this disease’s grim outlook, there is still hope.

“We are making progress with therapies and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a specialist.

For many individuals, however, awareness about this rare but {dev